7.87 USD
↘ 0.48 (5.75%)AT CLOSE (11:59 AM EDT)
Neuraxis, Inc.
NRXSAMEX • USD
7.86
↘ 0.01 (0.13%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
7.86
↘ 0.01 (0.13%)
Market: CLOSED
Open?$8.29
High?$8.29
Low?$7.70
Prev. Close?$8.35
Volume?114.1K
Avg. Volume?190.9K
VWAP?$7.88
Rel. Volume?0.60x
Bid / Ask
Bid?$7.80 × 100
Ask?$7.99 × 1.0K
Spread?$0.19
Midpoint?$7.90
Valuation & Ratios
Market Cap?97.5M
Shares Out?11.5M
Float?6.3M
Float %?56.2%
P/E Ratio?N/A
P/B Ratio?16.96
EPS?-$0.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Employees
24
Market Cap
97.5M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
Listed
2023-08-09
Address
11611 N. MERIDIAN ST
CARMEL, IN 46032
Phone: (812) 689-0791
CARMEL, IN 46032
Phone: (812) 689-0791
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.89Strong
Quick Ratio?2.81Strong
Cash Ratio?2.52Strong
Debt/Equity?0.02Low
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?16.96HIGH▾
P/S?22.76HIGH▾
P/FCF?N/A▾
EV/EBITDA?-12.6CHEAP▾
EV/Sales?21.13HIGH▾
Returns & Efficiency
ROE?-140.5%WEAK▾
ROA?-92.3%WEAK▾
Cash Flow & Enterprise
FCF?$-6072095
Enterprise Value?$90.5M
Fundamentals ratios updated end of day